Large language models (LLMs) aren’t actually giant computer brains. Instead, they are effectively massive vector spaces in ...

Faculty members at Northeast Community College are beginning to integrate artificial intelligence tools into their classrooms ...

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...

After 31 days with Molty, our persistent AI agent, the real question isn't whether memory makes AI more capable. It's what ...

Digital utopia is about humanity entering a new civilisational phase, of abundance, powered by two mutually reinforcing ...

The market overvalues AGI as LLMs plateau, but BRK.A and UNH leverage AI for gains while others face bubble risks. Find out ...

Could machines think? Yes, in a sense, they do already. Impressively. But could machines experience and feel? Only God knows.

The best systems programming books focus on both theory and hands-on practice, making tough topics easier to grasp. They ...

On Sunday at Memorial Park Golf Course, Gary Woodland authored one of the most inspirational chapters in the history of ...

A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...